Join Our Team

Career Opportunities

To be a part of our pioneering team of scientific investigators, please check our open positions. For consideration, please send your resume to us at careers@fatetherapeutics.com and reference the open position’s job code.

Open Positions

170SA, Senior Director, Quality

Job Code 170SA

Description

Fate Therapeutics is seeking an experienced Quality Assurance and Control professional to lead clinical stage development quality activities. In this key position, the individual will develop, implement, manage, audit, and maintain GxP (cGMP, GCP, and GLP) quality systems and will work across all disciplines (e.g., manufacturing, clinical development, research, and regulatory affairs) to ensure that Fate’s ongoing development program maintains regulatory compliance with local, state, federal, and international health authority requirements. Fate’s development programs involve novel cell therapies which present with unique product manufacturing, quality, and regulatory challenges. The ideal candidate should have experience in the area of cell therapy and/or biologics and knowledge of the pertinent regulations and how they apply to these fields. This is a full-time position reporting to the Chief Development Officer and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 170SA.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

169LR, Senior Quality Assurance Associate / Quality Assurance Associate

Job Code 169LR

Description

Fate Therapeutics is seeking an experienced Quality Assurance professional to support clinical stage development quality assurance and manufacturing activities. Under the direction of the Associate Director, Quality Assurance, this position is expected to write and review SOPs and batch records, process incoming raw material receipt and release, and manage release of products. Fate’s development programs involve novel cell therapies which present with unique product manufacturing, quality and regulatory challenges. The ideal candidate should have experience in the area of cell therapy and/or biologics and be aware of the pertinent regulations and how they apply to these fields. This is a full-time position currently reporting to the Associate Director, Quality Assurance and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 169LR.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

168AM, Manufacturing Operations Associate

Job Code 168AM

Description

Fate Therapeutics is seeking an experienced Manufacturing Operations Associate to support clinical-stage development lab operation and manufacturing activities.  Under the direction of the Director of Process Development and Manufacturing, this position is expected to manage incoming raw material receipt and release for internal and external manufacturing operations, facilitate quality control  (QC) testing of materials and products, and operation of Fate’s Manufacturing laboratories including equipment and monitoring.  Fate’s development programs involve novel cell therapeutic products which present unique product manufacturing and quality opportunities.  The ideal candidate will have experience in raw material management and laboratory operations. Cell therapy manufacturing knowledge and familiarity with the pertinent regulations and how they apply to this field is desired.  This is a full-time position currently reporting to the Director of Process Development and Manufacturing and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 168AM.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

166JK, Director / Associate Director / Senior Manager, Data Management

Job Code 166JK

Description

Fate’s Biometrics team is currently seeking a skilled and motivated data management professional to contribute to and manage the database development and ongoing quality of the data for the Company’s clinical trials. This is a full-time position reporting to the Vice President, Biometrics and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 166JK.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Fate Therapeutics is headquartered in San Diego, CA.

165DR, Scientist, Genome Biology

Job Code 165DR

Description

Fate Therapeutics is seeking a highly motivated and innovative research investigator with significant expertise in human genome characterization studies. By employing the latest genomics technologies utilizing the latest advancements in NGS, this position will be responsible for the establishment of methods to characterize and fully understand Fate’s novel induced pluripotent stem cell derived cellular therapy product candidates. The candidate must also have extensive experience in molecular biology including cloning, real-time PCR, and most importantly, skills related to the characterization of human genomes by NGS (DNA-seq, WES, CNV, etc.). The successful individual will demonstrate subject matter expertise combined with the ability to independently evaluate large amounts of scientific data required for detailed characterization of cell-based immuno-therapeutics. This is a full-time position reporting to the Associate Director, Genomics and is located at our corporate headquarters in San Diego.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 165DR.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Fate Therapeutics is headquartered in San Diego, CA.

164BV, Associate Director / Senior Scientist, Cancer Immunotherapy

Job Code 164BV

Description

Fate’s Cancer Immunotherapy group is seeking a talented and highly motivated scientist with expertise in oncology and stroma immunobiology to join a multidisciplinary team dedicated to the discovery of novel cellular therapeutics for the treatment of cancer. The successful candidate will play a leading role in the research and translation of new biologic modalities for off-the-shelf cancer immunotherapy. Specifically, the candidate will be tasked to drive ongoing efforts to identify novel strategies to improve effector persistence across tumor microenvironment and histocompatibility barrier. The candidate must have in depth knowledge of NK cell and T cell immunology, cancer biology, effector cell dysfunction and exhaustion, immunosuppression, metabolism and trafficking. The position will require independent research as well as coordination with the greater cancer immunotherapy and cellular engineering groups. This is a full-time position reporting to the Vice President of Cancer Immunotherapy and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 164BV.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

163RC, Scientist, Cancer Immunotherapy

Job Code 163RC

Description

Fate’s Cancer Immunotherapy group is seeking an experienced and highly motivated cell biologist with expertise in T cell immunology and developmental biology to join a multidisciplinary team dedicated to the discovery of novel off-the-shelf cellular therapeutics for the treatment of cancer and other disorders. The successful candidate will be responsible for optimization and execution of novel T and CAR-T lymphoid differentiation protocols from induced pluripotent stem cells (iPSC), their subsequent scale-up and application to therapeutic indications. In addition, the candidate will be responsible for the functional assessment of iPSC-derived T and CAR-T cells in both in vitro and in vivo models. The candidate must have in depth knowledge of T cell immunology in addition to extensive experience with mammalian cell culture. The position will require individual, independent research as well as coordination with the reprogramming biology and engineering, immunology, in vivo biology and process development groups. This is a full-time position reporting to the Senior Scientist, Cancer Immunotherapy, and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 163RC.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Fate Therapeutics is headquartered in San Diego, CA.

161BR, Scientist / Associate Scientist, Hematopoietic Differentiation and Translation

Job Code 161BR

Description

Fate’s Hematopoietic Differentiation and Translation team is currently seeking a skilled and motivated cell biologist to support the company’s off-the-shelf cellular immunotherapy translational programs. The successful candidate will join a multidisciplinary team pursuing the derivation of hematopoietic cells, particularly engineered hematopoietic progenitor stem cells (eHPSCs), from iPSCs for cellular therapeutic purposes. The candidate will perform, optimize and analyze experiments involving the in vitro differentiation, expansion and production of iPSCs towards eHPSCs. Candidates must have extensive cell culture experience, in particular with embryonic stem cells (ESCs) or iPSCs, and a knowledge of the hematopoietic system and immunology is preferred. This position will require independent research and coordination with the company’s iPSC engineering and reprogramming team, as well as process development groups. This is a full-time position and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 161BR.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Fate Therapeutics is headquartered in San Diego, CA.

159SW, Senior Director / Director, Corporate Communications & Investor Relations

Job Code 159SW

Description

Fate Therapeutics is seeking an experienced Corporate Communications & Investor Relations professional to proactively develop, implement and manage the Company’s communications and investor relations strategies and programs. Under the direction of the CEO, this position is expected to develop key communications strategies, mainly addressing the investor community, and shape cohesive external communications plans. He/she is required to be a strong writer and presenter, with the ability to understand and translate complicated science and concepts into easy to digest messages for broad audiences. This is a full-time position currently reporting to the CEO and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 159SW.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.